Cutting edge: CD8 T cells specific for lymphocytic choriomeningitis virus require type IIFN receptor for clonal expansion

被引:138
作者
Aichele, P
Unsoeld, H
Koschella, M
Schweier, O
Kalinke, U
Vucikuja, S
机构
[1] Univ Freiburg, Dept Immunol, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany
[2] Paul Ehrlich Inst, Dept Immunol, D-6070 Langen, Germany
关键词
D O I
10.4049/jimmunol.176.8.4525
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of type I IFN signaling in CD8 T cells was analyzed in an adoptive transfer model using P14 TCR transgenic CD8 T cells specific for lymphocytic choriomeningitis virus (LCMV) but deficient in type I IFNR. In the present study, we demonstrate severe impairment in the capacity of P14 T cells lacking type I IFNR to expand in normal type I IFNR wild-type C57BL/6 hosts after LCMV infection. In contrast, following infection of recipient mice with recombinant vaccinia virus expressing LCMV glycoprotein, P14 T cell expansion was considerably less dependent on type I IFNR expression. Lack of type I IFNR expression by P14 T cells did not affect cell division after LCMV infection but interfered with clonal expansion. Thus, direct type I IFN signaling is essential for CD8 T cell survival in certain viral infections.
引用
收藏
页码:4525 / 4529
页数:5
相关论文
共 24 条
[1]   Interferons α and β as immune regulators -: A new look [J].
Biron, CA .
IMMUNITY, 2001, 14 (06) :661-664
[2]   Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon [J].
Cella, M ;
Jarrossay, D ;
Facchetti, F ;
Alebardi, O ;
Nakajima, H ;
Lanzavecchia, A ;
Colonna, M .
NATURE MEDICINE, 1999, 5 (08) :919-923
[3]   Cutting edge: Type IIFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation [J].
Curtsinger, JM ;
Valenzuela, JO ;
Agarwal, P ;
Lins, D ;
Mescher, MF .
JOURNAL OF IMMUNOLOGY, 2005, 174 (08) :4465-4469
[4]   Type IIFN negatively regulates CD8+ T cell responses through IL-10-Producing CD4+ T regulatory 1 cells [J].
Dikopoulos, N ;
Bertoletti, A ;
Kröger, A ;
Hauser, H ;
Schirmbeck, R ;
Reimann, J .
JOURNAL OF IMMUNOLOGY, 2005, 174 (01) :99-109
[5]   Down-modulation of responses to type IIFN upon T cell activation [J].
Dondi, E ;
Rogge, L ;
Lutfalla, G ;
Uzé, G ;
Pellegrini, S .
JOURNAL OF IMMUNOLOGY, 2003, 170 (02) :749-756
[6]   A critical function for type I interferons in cancer immunoediting [J].
Dunn, GP ;
Bruce, AT ;
Sheehan, KCF ;
Shankaran, V ;
Uppaluri, R ;
Bui, JD ;
Diamond, MS ;
Koebel, CM ;
Arthur, C ;
White, JM ;
Schreiber, RD .
NATURE IMMUNOLOGY, 2005, 6 (07) :722-729
[7]   Listeria-infected myeloid dendritic cells produce IFN-β priming T cell activation [J].
Feng, HP ;
Zhang, D ;
Palliser, D ;
Zhu, PC ;
Cai, SH ;
Schlesinger, A ;
Maliszewski, L ;
Lieberman, J .
JOURNAL OF IMMUNOLOGY, 2005, 175 (01) :421-432
[8]   Interferon α augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression [J].
Kaser, A ;
Nagata, S ;
Tilg, H .
CYTOKINE, 1999, 11 (10) :736-743
[9]   Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon [J].
Le Bon, A ;
Etchart, N ;
Rossmann, C ;
Ashton, M ;
Hou, S ;
Gewert, D ;
Borrow, P ;
Tough, DF .
NATURE IMMUNOLOGY, 2003, 4 (10) :1009-1015
[10]   Type 1 IFN maintains the survival of anergic CD4+ T cells [J].
Lombardi, G ;
Dunne, PJ ;
Scheel-Toellner, D ;
Sanyal, T ;
Pilling, D ;
Taams, LS ;
Life, P ;
Lord, JM ;
Salmon, M ;
Akbar, AN .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3782-3789